Gritstone Oncology
Latest round
- Series B
Last raised
- Sep 2017
Total raised
- $195M
Investors
- 10
About Gritstone Oncology
Based in the US, Gritstone Oncology, Inc.Gritstone Oncology specializes in creating innovative immunotherapies for cancer treatment. Founded in 2015, the company is headquartered in Emeryville, US. The founders, Andrew Allen, Graham Lord, and Mark Cobbold, have a history of involvement in the biotech sector.Gritstone Oncology is primarily focused on developing innovative immunotherapies for cancer treatment. Their core product offering centers around personalized neoantigen therapies, which are designed to harness the body's immune system to target and destroy cancer cells. These therapies aim to provide customized treatment options based on the specific mutations present in an individual’s tumor, thus addressing the unique characteristics of each patient's cancer. Their flagship products include a range of neoantigen-based therapies currently in various stages of clinical development, targeting indications such as non-small cell lung cancer and other solid tumors.32 mn. The company's revenue model is structured around partnerships and collaborations with pharmaceutical companies and healthcare providers, typically involving licensing agreements and joint development programs.Gritstone Oncology aims to enhance its product offerings by developing new personalized cancer therapies, though specific launch dates have not been disclosed. The company is also looking to expand its presence in international markets, particularly in Europe and Asia, to meet the growing demand for advanced cancer treatments.99 mn will support these initiatives by facilitating further research and development efforts, as well as broadening their market reach. Notably, Casdin Capital, Clarus Ventures, The Column Group, Alexandria Venture Investments, GV, Lilly Asia Ventures, and Trinitas Capital have fully exited their stake in Gritstone Oncology, Inc.
Who invested in Gritstone Oncology
10 investors across 2 rounds
See all investors in Gritstone Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gritstone Oncology
Who invested in Gritstone Oncology?
Gritstone Oncology has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gritstone Oncology raised?
Gritstone Oncology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Gritstone Oncology last raise money?
Gritstone Oncology's most recent round on record is a Series B, in Sep 2017.
What does Gritstone Oncology do?
Based in the US, Gritstone Oncology, Inc.
Where is Gritstone Oncology headquartered?
Gritstone Oncology is headquartered in Emeryville, US.
Which VCs invest in companies like Gritstone Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Gritstone Oncology's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Gritstone Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.